How to reconstitute Tirzepatide: mixing and storage

A weekly GIP/GLP-1 injection with strong diabetes and weight-loss evidence and common stomach side effects.

Also called: Mounjaro, Zepbound, LY3298176, LY-3298176, Tirz.

GLP-1 / GIP / glucagon agonists · Dual GIP and GLP-1 receptor agonist · Evidence: Approved drug.

Comes as: Label: ready-to-use solution in single-dose pen or vial., Label: multi-dose vial or four-dose KwikPen., Community: lyophilized powder vials..

Mixed with: Label products need no diluent. Community powder reports use bacteriostatic water; this does not establish sterility or stability..

Common vial sizes: 10, 30 mg. Common water amounts: 1, 2, 3 mL.

  • Community examples: 10 mg with 1–2 mL; 30 mg with 3 mL. These are reports, not validated pharmaceutical recipes.
  • Community mixed-vial beyond-use dating is unknown. Bacteriostatic water does not sterilize contaminated powder.
  • Label strengths: 2.5–15 mg per 0.5 mL single dose; four-dose devices provide each dose in 0.6 mL.
  • Read the actual presentation instructions; do not transfer a single-dose storage rule to a multi-dose product.

Before mixing: Label solution: 2–8°C, protected from light; never freeze. Community powder: no verified shelf life or universal storage rule.

After mixing: Label single-dose: ≤30°C for up to 21 total days. Multi-dose/KwikPen: discard by 30 days after first use, 30 room-temp days, or 4 weekly doses.

Zepbound single-dose pens and vials: keep at 2-8 C in the carton; do not freeze. Up to 21 total days at 30 C or below is allowed; discard single-dose devices after use.

Related to Tirzepatide

Sources

Sources checked: 2026-10-18.

Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.